Zevacor

Zevacor was a U.S. radiopharmaceutical company focused on molecular imaging and nuclear medicine products and services. The business included Zevacor Pharma, which developed, manufactured, and distributed PET and SPECT radiopharmaceuticals through a radiopharmacy and contract manufacturing network, and Zevacor Molecular, which produced radioisotopes such as strontium-82 used for rubidium-82 cardiac PET imaging. Zevacor served both clinical and research markets and offered supporting services for diagnostic tracer development and radiolabeling. The Zevacor businesses were split through acquisitions: Zevacor Pharma was acquired by SOFIE in 2017 and Zevacor Molecular was acquired by Curium in 2020, after which the Zevacor name was rebranded under the respective acquirers.